Die obligate intraoperative Cholangiographie bei der laparoskopischen Cholezystektomie – Erfahrungen nach 1500 Operationen

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Die iatrogene Gallenwegsverletzung stellt trotz zunehmender Erfahrung ein schwerwiegendes Risiko der laparoskopischen Cholezystektomie dar. Zur Erhöhung der Patientensicherheit führten wir daher die obligate intraoperative Cholangiographie ein und konnten dadurch die Röntgenquote von vorher 28% auf 97,4% bei den letzten 1500 Operationen steigern. Trotz dieser Maβnahmen sank die durchschnittliche Operationsdauer von 56 auf 40 min. Gleichzeitig konnten wir die Rate an Gallenwegsläsionen von 1,5 auf 0,3% reduzieren. Eine vorher nicht bekannte Choledocholithiasis wurde in 4,4% der Fälle entdeckt und durch postoperative endoskopische retrograde Cholangiographie behandelt.

Related collections

Author and article information

Journal

Journal ID (publisher-id): CGA

Journal ID (pmc): VIS

Journal ID (doi): 10.1159/issn.2297-4725

Title: Visceral Medicine

Publisher: S. Karger AG

ISBN: 978-3-8055-6455-7

ISBN: 978-3-318-01813-4

ISSN (Print): 2297-4725

ISSN (Electronic): 2297-475X

Publication date Subscription-year: 1996

Publication date (Print): 1996

Publication date (Electronic): 23 December 2008

Volume: 12

Issue: Suppl 2

Pages: 17-20

Affiliations

Allgemeinchirurgische Abteilung, St. Vincenz- und Elisabeth-Hospital, Mainz

Article

Publisher ID: 190021 Other ID: Chir Gastroenterol 1996;12:17–20

DOI: 10.1159/000190021

SO-VID: b9795b9a-d6e1-4d6e-9ecc-67023e035649

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

History

Page count

Pages: 4

Comments

Comment on this article

Cited by 1

Angiogenic Growth Factors: A Review for Tissue Engineering
Authors: Gretchen Ahrendt, Donald E. Chickering, John Ranieri

See all cited by

Call for Papers: Controversial Issues in Gastroenterology

Submit here by October 31, 2025